Back
Mirum Pharmaceuticals Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
34
MIRM
Mirum Pharmaceuticals
Last Price:
$39.08
Seasonality Move:
11.84%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.
Mirum Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.45 | Sell |
| 20-day SMA: | 42.77 | Sell |
| 50-day SMA: | 46.06 | Sell |
| 200-day SMA: | 42.56 | Sell |
| 8-day EMA: | 39.79 | Sell |
| 20-day EMA: | 41.87 | Sell |
| 50-day EMA: | 44.09 | Sell |
| 200-day EMA: | 41.54 | Sell |
Mirum Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.03 | Sell |
| Relative Strength Index (14 RSI): | 34.64 | Sell |
| Chaikin Money Flow: | 156027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.23 - 46.49) | Sell |
| Bollinger Bands (100): | (41.69 - 48.75) | Sell |
Mirum Pharmaceuticals Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mirum Pharmaceuticals Stock
Is Mirum Pharmaceuticals Stock a Buy?
-
Mirum Pharmaceuticals share price is 39.10 while MIRM 8-day simple moving average is 39.45, which is a Sell signal.
-
The stock price of MIRM is 39.10 while Mirum Pharmaceuticals 20-day SMA is 42.77, which makes it a Sell.
-
Mirum Pharmaceuticals 50-day simple moving average is 46.06 while MIRM share price is 39.10, making it a Sell technically.
-
MIRM stock price is 39.10 and Mirum Pharmaceuticals 200-day simple moving average is 42.56, creating a Sell signal.
MIRM Technical Analysis vs Fundamental Analysis
Sell
34
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy or a Sell?
-
Mirum Pharmaceuticals stock is rated a SellThe current Mirum Pharmaceuticals [MIRM] share price is $39.10. The Score for MIRM is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Mirum Pharmaceuticals Stock Info
Market Cap:
1.9B
Price in USD:
39.10
Share Volume:
429.1K
Mirum Pharmaceuticals 52-Week Range
52-Week High:
54.23
52-Week Low:
23.14
Sell
34
Mirum Pharmaceuticals (MIRM)
is a Sell
Mirum Pharmaceuticals Share Price Forecast
-
What is the Mirum Pharmaceuticals stock price today?The Mirum Pharmaceuticals stock price is 39.10 USD today.
-
Will MIRM stock go up or go down?Mirum Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Mirum Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mirum Pharmaceuticals is overvalued.
Is Mirum Pharmaceuticals Stock a Buy?
-
Mirum Pharmaceuticals share price is 39.10 while MIRM 8-day exponential moving average is 39.79, which is a Sell signal.
-
The stock price of MIRM is 39.10 while Mirum Pharmaceuticals 20-day EMA is 41.87, which makes it a Sell.
-
Mirum Pharmaceuticals 50-day exponential moving average is 44.09 while MIRM share price is 39.10, making it a Sell technically.
-
MIRM stock price is 39.10 and Mirum Pharmaceuticals 200-day simple moving average is 41.54, creating a Sell signal.
Fundamental Analysis of Mirum Pharmaceuticals
Is Mirum Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.61 per share, and an increase next year of $0.44 per share.
Technical Analysis of Mirum Pharmaceuticals
Should I short Mirum Pharmaceuticals stock?
-
MIRM Moving Average Covergence Divergence (MACD) indicator is -2.03, suggesting Mirum Pharmaceuticals is a Sell
-
Mirum Pharmaceuticals Relative Strength Index (RSI) is 34.64, which suggest Mirum Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Mirum Pharmaceuticals is (40.23 - 46.49), which suggest Mirum Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Mirum Pharmaceuticals is (41.69 - 48.75), which suggest Mirum Pharmaceuticals is a Sell
* Mirum Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.